The MEDiscuss VTE Engine automates the diagnostic algorithm to minimise unnecessary imaging and radiation exposure. It first establishes pre-test probability. For ‘Likely’ cases, it recommends immediate imaging (CUS for DVT, CTPA for PE). For ‘Unlikely’ cases, it seamlessly applies exclusion rules (PERC or YEARS) and precisely calculates age-adjusted D-dimer thresholds to safely exclude venous thromboembolism.
The PERC Rule MandateThe Pulmonary Embolism Rule-out Criteria (PERC) is strictly validated only for patients with a low pre-test probability (Wells’ score ≤ 4). It comprises 8 objective clinical variables. If a low-risk patient is PERC-negative (zero criteria met), PE is excluded with an overwhelmingly high confidence margin, obviating the need for D-dimer testing or CTPA.
Know your lab’s exact assay. D-dimer is reported in either Fibrinogen Equivalent Units (FEU) or D-Dimer Units (DDU). 500 μg/L FEU = 250 μg/L DDU. Applying the Age × 10 formula to a DDU assay will dangerously double the threshold, leading to fatal missed PEs. Always confirm the unit.
Subtracting 2 points for an “alternative diagnosis” heavily skews the result to “Unlikely”. Only select this if you have objective evidence (e.g., visible cellulitis, obvious trauma, ruptured Baker’s cyst on US). Do not select it simply based on an unverified hunch of a “muscle tear”.
- First-Line Therapy: NOACs (Apixaban, Rivaroxaban) are the standard of care for acute VTE. They do not require bridging with LMWH.
- Cancer-Associated Thrombosis (CAT): Apixaban and Rivaroxaban are preferred over LMWH for convenience, EXCEPT in gastrointestinal (GI) or genitourinary (GU) cancers, where NOACs have unacceptably high rates of mucosal bleeding. Use LMWH for GI/GU cancer patients.
- Antiphospholipid Syndrome (APS): NOACs are absolutely contraindicated. Use Warfarin (target INR 2.0 to 3.0).
Algorithm References & Evidence Base
- Wells PS, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003.
- Wells PS, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging. Ann Intern Med. 2001.
- Kline JA, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008.
- Schouten HJ, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients. BMJ. 2013.
- van der Hulle T, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study). Lancet. 2017.
Access all evidence-based algorithms, prognostic matrices, and pharmacotherapeutic pathways.
← View All Clinical Modules
